Skip to main content
Log in

Protective Effect of Selenium-Enriched Green Tea on Carbon Tetrachloride-Induced Liver Fibrosis

  • Published:
Biological Trace Element Research Aims and scope Submit manuscript

Abstract

The major pathogenic feature of liver fibrosis is that oxidative stress motivation of hepatic stellate cells (HSCs) alters the balance between the synthesis and degradation of extracellular matrix (ECM) and HSCs into proliferative myofibroblasts. Green tea and selenium (Se) can protect the liver from damage; however, the precise mechanism of green tea and the action of Se in green tea on hepatic fibrosis remain unclear. Several studies have demonstrated the profibrogenic role of 5-hydroxytryptamine (5-HT) and 5-hydroxytryptamine receptor (5-HTR) 2A/2B in the liver. The current study aimed to investigate the protective effects and possible mechanisms of selenium-enriched green tea on carbon tetrachloride (CCl4)-induced liver fibrosis in male C57BL/6 J mice. After a 4-week intervention with tea solution, histological analysis of the liver showed that green tea interventions alleviated hepatic fibrosis, which was supported by the changes in collagen type I, collagen type III, and α-smooth muscle actin in the liver. Tea interventions significantly inhibited the CCl4-provoked increase of duodenal 5-HT and tryptophan hydroxylase and hepatic 5-HT and 5-HTR2A/2B levels. All of them were lower in the selenium-enriched green tea group than in regular green tea group. Se-enriched green tea had a more pronounced improvement in liver ECM deposition and scar formation and peripheral 5-HT signals than regular green tea. Thus, green tea, especially those enriched with selenium, can improve liver fibrosis through intestinal 5-HT-hepatic 5-HTR signaling.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Data Availability

Not applicable.

Code Availability

Not applicable.

References

  1. Perepelyuk M, Terajima M, Wang AY, Georges PC, Janmey PA, Yamauchi M, Wells RG (2013) Hepatic stellate cells and portal fibroblasts are the major cellular sources of collagens and lysyl oxidases in normal liver and early after injury. Am J Physiol Gastrointest Liver Physiol 46:216–221. https://doi.org/10.1152/ajpgi.00222.2012

    Article  CAS  Google Scholar 

  2. Eyraud D (2015) Clinics and research in hepatology and gastroenterology. Editorial. Clin Res Hepatol Gastroenterol 39:151–152. https://doi.org/10.1016/j.clinre.2014.12.009

    Article  PubMed  Google Scholar 

  3. Fariborz MG, Amir H, Makan P, Farahnaz J, Sahar G, Ameneh N (2018) Green tea as a safe alternative approach for nonalcoholic fatty liver treatment: a systematic review and meta-analysis of clinical trials: green tea and Nafld. Phytother Res 32:1876–1884. https://doi.org/10.1002/ptr.6130

    Article  CAS  Google Scholar 

  4. Hu Y, McIntosh GH, Le Leu RK, Nyskohus LS, Woodman RJ, Young GP (2013) Combination of selenium and green tea improves the efficacy of chemoprevention in a rat colorectal cancer model by modulating genetic and epigenetic biomarkers. PLoS One 8:e64362. https://doi.org/10.1371/journal.pone.0064362

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Tecott LH (2007) Serotonin and the orchestration of energy balance. Cell Metab 6:352–361. https://doi.org/10.1016/j.cmet.2007.09.012

    Article  CAS  PubMed  Google Scholar 

  6. Choi W, Moon JH, Kim H (2020) Serotonergic regulation of energy metabolism in peripheral tissues. J Endocrinol 245:R1–R10. https://doi.org/10.1530/JOE-19-0546

    Article  CAS  PubMed  Google Scholar 

  7. Beaudry P, Hadengue A, Callebert J, Gaudin C, Soliman H, Moreau R, Launay JM, Lebrec D (1994) Blood and plasma 5-hydroxytryptamine levels in patients with cirrhosis. Hepatology 20:800–803. https://doi.org/10.1002/hep.1840200405

    Article  CAS  PubMed  Google Scholar 

  8. Li T, Weng SG, Leng XS, Peng JR, Wei YH, Mou DC, Wang WX (2006) Effects of 5-hydroxytamine and its antagonists on hepatic stellate cells. Hepatobiliary Pancreat Dis Int 5:96–100 https://www.ncbi.nlm.nih.gov/pubmed/16481292

    CAS  PubMed  Google Scholar 

  9. Chen L, Chen G, Guo Y, Liu L, Xiao L, Fan W, Shi B, Qian Y (2014) Ketanserin, a serotonin 2A receptor antagonist, alleviates ischemia-related biliary fibrosis following donation after cardiac death liver transplantation in rats. Liver Transpl 20:1317–1326. https://doi.org/10.1002/lt.23947

    Article  PubMed  Google Scholar 

  10. Ebrahimkhani MR, Oakley F, Murphy LB, Mann J, Moles A, Perugorria MJ, Ellis E, Lakey AF, Burt AD, Douglass A, Wright MC, White SA, Jaffré F, Maroteaux L, Mann DA (2011) Stimulating healthy tissue regeneration by targeting the 5-ht2b receptor in chronic liver disease. Nat Med 17:1668–1673. https://doi.org/10.1038/nm.2490

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Hung GD, Li PC, Lee HS, Chang HM, Chien CT, Lee KL (2012) Green tea extract supplementation ameliorates ccl4-induced hepatic oxidative stress, fibrosis, and acute-phase protein expression in rat. J Formos Med Assoc 111:550–559. https://doi.org/10.1016/j.jfma.2011.06.026

    Article  CAS  PubMed  Google Scholar 

  12. Tipoe G, Leung T, Liong E, Lau T, Fung M, Nanji A (2010) Epigallocatechin-3-gallate (EGCG) reduces liver inflammation, oxidative stress and fibrosis in carbon tetrachloride (CCl4)-induced liver injury in mice. Toxicology 273:45–52. https://doi.org/10.1016/j.tox.2010.04.014

    Article  CAS  PubMed  Google Scholar 

  13. Jing H, Wang S, Wang Y, Shen N, Gao XJ (2020) Environmental contaminant ammonia triggers epithelial-to-mesenchymal transition-mediated jejunal fibrosis with the disassembly of epithelial cell-cell contacts in chicken. Sci Total Environ 726:138686. https://doi.org/10.1016/j.scitotenv.2020.138686

    Article  CAS  PubMed  Google Scholar 

  14. Imperiale TF, Said AT, Cummings OW, Born LJ (2000) Need for validation of clinical decision aids: use of the AST/ALT ratio in predicting cirrhosis in chronic hepatitis C. Comparative Study. Am J Gastroenterol 95:2328–2332. https://doi.org/10.1111/j.1572-0241.2000.02322.x

    Article  CAS  PubMed  Google Scholar 

  15. Guéchot J, Boisson RC, Zarski JP, Sturm N, Calès P, Lasnier E, ANRS HCEP 23 Fibrostar Group (2013) AST/ALT ratio is not an index of liver fibrosis in chronic hepatitis C when aminotransferase activities are determinate according to the international recommendations. Clin Res Hepatol Gastroenterol 37:467–472. https://doi.org/10.1016/j.clinre.2013.07.003

    Article  CAS  PubMed  Google Scholar 

  16. Li W, Wu Y, Zhu C, Wang Z, Gao R, Wu Q (2014) Anti-fibrosis effects of Huisheng oral solution in CCl4-induced hepatic fibrosis in rat. Indian J Pharmacol 46:216–221. https://doi.org/10.4103/0253-7613.129323

    Article  PubMed  PubMed Central  Google Scholar 

  17. Chen A, Zhang L, Xu J, Tang J (2002) The antioxidant (-)-epigallocatechin-3-gallate inhibits activated hepatic stellate cell growth and suppresses acetaldehyde-induced gene expression. Biochem J 368:695–704. https://doi.org/10.1042/BJ20020894

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Yasuda Y, Shimizu M, Sakai H, Iwasa J, Kubota M, Adachi S, Osawa Y, Tsurumi H, Hara Y, Moriwaki H (2009) (-)-Epigallocatechin gallate prevents carbon tetrachloride-induced rat hepatic fibrosis by inhibiting the expression of the Pdgfrbeta and Igf-1r. Chem Biol Interact 182:159–164. https://doi.org/10.1016/j.cbi.2009.07.015

    Article  CAS  PubMed  Google Scholar 

  19. Jia L, Wang T, Sun Y, Zhang M, Cui J (2019) Protective effect of selenium-enriched red radish sprouts on carbon tetrachloride-induced liver injury in mice. J Food Sci 84:3027–3036. https://doi.org/10.1111/1750-3841.14727

    Article  CAS  PubMed  Google Scholar 

  20. Ding M, Potter JJ, Liu X, Torbenson MS, Mezey E (2010) Selenium supplementation decreases hepatic fibrosis in mice after chronic carbon tetrachloride administration. Biol Trace Elem Res 133:83–97. https://doi.org/10.1007/s12011-009-8414-x

    Article  CAS  PubMed  Google Scholar 

  21. Thuluvath PJ, Triger DR (1992) Selenium in chronic liver disease. J Hepatol 14:176–182. https://doi.org/10.1016/0168-8278(92)90155-i

    Article  CAS  PubMed  Google Scholar 

Download references

Funding

This work was financially supported by the Special Project of Innovation-Driven Development in Guangxi (Grant No. Guike AA17202038-3) and the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD).

Author information

Authors and Affiliations

Authors

Contributions

Li-Qiang Qin, Jia-Ying Xu, and Minghua Gu designed the study. Lin Zhang, Yanyan Wei, Shi-Lin Gao, Lin Wang, and Jia-Yang Zheng conducted the research. Lin Zhang performed the statistical tests and wrote the original draft. Li-Qiang Qin and Jia-Ying Xu edited the final paper.

Corresponding author

Correspondence to Li-Qiang Qin.

Ethics declarations

Ethics Approval

Approved by the Soochow University Animal Welfare Committee (Grant No. 201905A414).

Consent to Participate

Not applicable.

Consent for Publication

Not applicable.

Conflict of Interest

The authors declare no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zhang, L., Xu, JY., Wei, Y. et al. Protective Effect of Selenium-Enriched Green Tea on Carbon Tetrachloride-Induced Liver Fibrosis. Biol Trace Elem Res 200, 2233–2238 (2022). https://doi.org/10.1007/s12011-021-02823-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12011-021-02823-x

Keywords

Navigation